Clinical outcomes with the MammoSite radiation therapy system: results of a prospective trial
Conclusion
APBI delivered with the MammoSite RTS is a feasible, tolerable, and effective treatment modality. Multicenter, randomized, controlled clinical trials with a larger number of patients are required for verification.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Clinical Trials | Radiation Therapy | Skin | Study | Toxicology